Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment?

By Todd Campbell
September 13, 2014

One of the most contentious debates surrounding medical marijuana is whether its use could help millions of people suffering from schizophrenia. For decades, the conventional wisdom has been that marijuana, at a minimum, triggers the disease, or at a maximum, causes it. However, research conducted over the past decade is prompting many to question that long-standing belief.

That research has found that while THC, the marijuana cannibinoid responsible for the “high,” can hasten the onset of schizophrenia, CBD, another marijuana cannibinoid, may reduce symptoms. That research has compelled U.K. drugmaker GW Pharmaceuticals (NASDAQ: GWPH ) to develop a synthetic variation of CBD that it is studying in clinical trials as a schizophrenia treatment.

http://www.fool.com/investing/general/2014/09/13/is-medical-marijuana-destined-to-become-a-top-schi.aspx